These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38470020)

  • 1. Half-dose direct oral anticoagulation versus warfarin for atrial fibrillation following cardiac surgery.
    Hashim SW; Collazo S; Greco A; Mather JF; McKay RG
    J Cardiovasc Surg (Torino); 2024 Apr; 65(2):169-176. PubMed ID: 38470020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Vitamin K Antagonist Oral Anticoagulant vs Warfarin for Post Cardiac Surgery Atrial Fibrillation.
    Nauffal V; Trinquart L; Osho A; Sundt TM; Lubitz SA; Ellinor PT
    Ann Thorac Surg; 2021 Nov; 112(5):1392-1401. PubMed ID: 33440173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
    Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight.
    Perales IJ; San Agustin K; DeAngelo J; Campbell AM
    Ann Pharmacother; 2020 Apr; 54(4):344-350. PubMed ID: 31672028
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry.
    Sherwood MW; Piccini JP; Holmes DN; Pieper KS; Steinberg BA; Fonarow GC; Allen LA; Naccarelli GV; Kowey PR; Gersh BJ; Mahaffey KW; Singer DE; Ansell JE; Freeman JV; Chan PS; Reiffel JA; Blanco R; Peterson ED; Rao SV
    Circ Cardiovasc Interv; 2020 May; 13(5):e008274. PubMed ID: 32408815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct oral anticoagulants for atrial fibrillation in early postoperative valve repair or bioprosthetic replacement.
    Moser N; Omar MA; Koshman SL; Lin M; Youngson E; Kent W; Harten C
    J Thorac Cardiovasc Surg; 2024 Aug; 168(2):523-532.e3. PubMed ID: 37061910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Anticoagulants for Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Pilot Study.
    Chapin TW; Leedahl DD; Brown AB; Pasek AM; Sand MG; Loy ML; Dyke CM
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):523-530. PubMed ID: 32476465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.
    Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH
    Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005894. PubMed ID: 32160790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Oral Anticoagulants Compared to Warfarin for Postoperative Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting.
    Woldendorp K; Khadra S; Bannon PG; Robinson BM
    Heart Lung Circ; 2020 Dec; 29(12):1832-1838. PubMed ID: 32622911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors That Affect Time to Switch From Warfarin to a Direct Oral Anticoagulant After Change in the Reimbursement Criteria in Patients With Atrial Fibrillation.
    Park S; Je NK
    J Cardiovasc Pharmacol Ther; 2020 Jan; 25(1):57-64. PubMed ID: 31405298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.
    Kerneis M; Gibson CM; Chi G; Mehran R; AlKhalfan F; Talib U; Pahlavani S; Mir M; Bode C; Halperin JL; Nafee T; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Fox KAA; Cohen M
    JACC Cardiovasc Interv; 2018 Apr; 11(7):626-634. PubMed ID: 29550085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting and Long-Term Outcome: A Population-Based Nationwide Study From the SWEDEHEART Registry.
    Taha A; Nielsen SJ; Bergfeldt L; Ahlsson A; Friberg L; Björck S; Franzén S; Jeppsson A
    J Am Heart Assoc; 2021 Jan; 10(1):e017966. PubMed ID: 33251914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Oral Anticoagulants for Atrial Fibrillation in Patients After Bariatric Surgery.
    Hendricks AK; Zieminski JJ; Yao X; Dunlay SM; Sangaralingham LR; O'Meara JG; Herrin TR; Nei SD
    Am J Cardiol; 2020 Dec; 136():76-80. PubMed ID: 32941819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016.
    Alcusky M; McManus DD; Hume AL; Fisher M; Tjia J; Lapane KL
    J Am Heart Assoc; 2019 May; 8(9):e012023. PubMed ID: 31046504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Effectiveness and Safety of Direct Oral Anticoagulants in Elderly Patients With Nonvalvular Atrial Fibrillation Who Are Not Candidates for Warfarin in Real-World Setting.
    Lo CT; Niu F; Fredriks DA; Hui RL
    J Cardiovasc Pharmacol; 2022 Jan; 79(1):e138-e143. PubMed ID: 34740212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Chan YH; Lee HF; Chao TF; Wu CT; Chang SH; Yeh YH; See LC; Kuo CT; Chu PH; Wang CL; Lip GYH
    Cardiovasc Drugs Ther; 2019 Dec; 33(6):701-710. PubMed ID: 31745687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New onset postoperative atrial fibrillation and early anticoagulation after cardiac surgery.
    Maaroos M; Pohjantähti-Maaroos H; Halonen J; Vähämetsä J; Turtiainen J; Rantonen J; Hakala T; Mennander AA; Hartikainen J
    Scand Cardiovasc J; 2017 Dec; 51(6):323-326. PubMed ID: 28990803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.